BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22011534)

  • 21. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens.
    Marcos M; Soriano A; Iñurrieta A; Martínez JA; Romero A; Cobos N; Hernández C; Almela M; Marco F; Mensa J
    J Antimicrob Chemother; 2011 Sep; 66(9):2119-25. PubMed ID: 21665905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Central Venous Catheter-Associated Bloodstream Infection in Pediatric Patients: A Cohort Study.
    Carter JH; Langley JM; Kuhle S; Kirkland S
    Infect Control Hosp Epidemiol; 2016 Aug; 37(8):939-945. PubMed ID: 27139311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010.
    Fagan RP; Edwards JR; Park BJ; Fridkin SK; Magill SS
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):893-9. PubMed ID: 23917902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central Venous Catheter Management in High-risk Children With Bloodstream Infections.
    Hecht SM; Ardura MI; Yildiz VO; Ouellette CP
    Pediatr Infect Dis J; 2020 Jan; 39(1):17-22. PubMed ID: 31725118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central Venous Catheter Salvage in Ambulatory Central Line-Associated Bloodstream Infections.
    Ford WJH; Bundy DG; Oyeku S; Heo M; Saiman L; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Klein E; Obaro-Best O; Drasher M; Peshansky A; Rinke ML
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in Pediatric Central Line-associated Bloodstream Infections Treated With Antimicrobial Locks: A 14-Year Retrospective Analysis.
    Walker LW; Visweswaran S; Nowalk AJ
    Pediatr Infect Dis J; 2023 Jun; 42(6):473-478. PubMed ID: 36854127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burn-associated bloodstream infections in pediatric burn patients: Time distribution of etiologic agents.
    Devrim İ; Kara A; Düzgöl M; Karkıner A; Bayram N; Temir G; Şencan A; Sorguç Y; Gülfidan G; Hoşgör M
    Burns; 2017 Feb; 43(1):144-148. PubMed ID: 27615546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of 2015 NHSN Catheter-associated Urinary Tract Infection (CAUTI) Definition Change on Central Line-associated Bloodstream Infection (CLABSI) Rates and CLABSI Prevention Efforts at an Academic Medical Center.
    Advani SD; Lee RA; Long M; Schmitz M; Camins BC
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):878-880. PubMed ID: 29665877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care.
    Toscano CM; Bell M; Zukerman C; Shelton W; Novicki TJ; Nichols WG; Corey L; Jarvis WR
    Am J Infect Control; 2009 May; 37(4):327-34. PubMed ID: 19406332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.
    See I; Freifeld AG; Magill SS
    Clin Infect Dis; 2016 May; 62(10):1203-9. PubMed ID: 26936664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
    McDonald MK; Culos KA; Gatwood KS; Prow C; Chen H; Savani BN; Byrne M; Kassim AA; Engelhardt BG; Jagasia M; Satyanarayana G
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2081-2087. PubMed ID: 29753159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies.
    Digiorgio MJ; Fatica C; Oden M; Bolwell B; Sekeres M; Kalaycio M; Akins P; Shane C; Bako J; Gordon SM; Fraser TG
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):865-8. PubMed ID: 22869258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
    Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating application of the National Healthcare Safety Network central line-associated bloodstream infection surveillance definition: a survey of pediatric intensive care and hematology/oncology units.
    Gaur AH; Miller MR; Gao C; Rosenberg C; Morrell GC; Coffin SE; Huskins WC
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):663-70. PubMed ID: 23739069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
    Oladapo-Shittu O; Cosgrove SE; Rock C; Hsu YJ; Klein E; Harris AD; Mejia-Chew C; Saunders H; Ching PR; Gadala A; Mayoryk S; Pineles L; Maragakis L; Salinas A; Helsel T; Keller SC
    Clin Infect Dis; 2024 Jun; 78(6):1632-1639. PubMed ID: 38483930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central line-associated bloodstream infection in childhood malignancy: Single-center experience.
    Miliaraki M; Katzilakis N; Chranioti I; Stratigaki M; Koutsaki M; Psarrou M; Athanasopoulos E; Stiakaki E
    Pediatr Int; 2017 Jul; 59(7):769-775. PubMed ID: 28376269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
    Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
    Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients.
    Rinke ML; Chen AR; Bundy DG; Colantuoni E; Fratino L; Drucis KM; Panton SY; Kokoszka M; Budd AP; Milstone AM; Miller MR
    Pediatrics; 2012 Oct; 130(4):e996-e1004. PubMed ID: 22945408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.